356 related articles for article (PubMed ID: 30101939)
21. Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review.
Zhu L; Wang L; Shi H; Jiang L; Li X; Shao C; Yan Y; Dong B; Zou W; Zuo L
Ren Fail; 2023 Dec; 45(1):2145970. PubMed ID: 36632756
[TBL] [Abstract][Full Text] [Related]
22. Non-crystalline light chain proximal tubulopathy associated with monoclonal gammopathy of renal significance: A case report and review of the literature.
Li F; Xie X; Sun L; Zhang Z; Chen J; Wang X
Clin Nephrol; 2023 Jan; 99(1):32-40. PubMed ID: 36444974
[TBL] [Abstract][Full Text] [Related]
23. IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay.
Djidjik R; Lounici Y; Chergeulaïne K; Berkouk Y; Mouhoub S; Chaib S; Belhani M; Ghaffor M
Pathol Biol (Paris); 2015 Sep; 63(4-5):210-4. PubMed ID: 26294067
[TBL] [Abstract][Full Text] [Related]
24. Glomerular, Mesangial, and Tubular Cytoplasmic Fibrillary Inclusions in a Patient with Light-Chain Proximal Tubulopathy.
Chung EYM; McIlroy K; Fung C; Seshan SV; Moran S; Coleman PL
Nephron; 2020; 144(4):190-194. PubMed ID: 32018256
[TBL] [Abstract][Full Text] [Related]
25. Loss of tubular creatinine secretion as the only sign of tubular proximal cell dysfunction in light chain proximal tubulopathy: A case report.
Stehlé T; Vignon M; Flamant M; Figueres ML; Rabant M; Rodenas A; Noël LH; Arnulf B; Vidal-Petiot E
Medicine (Baltimore); 2016 Jun; 95(26):e3815. PubMed ID: 27367983
[TBL] [Abstract][Full Text] [Related]
26. Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy.
Kapur U; Barton K; Fresco R; Leehey DJ; Picken MM
Arch Pathol Lab Med; 2007 Sep; 131(9):1368-72. PubMed ID: 17824791
[TBL] [Abstract][Full Text] [Related]
27. Light chain proximal tubulopathy without crystals in a case of Burkitt lymphoma presenting with acute kidney injury.
Rane S; Rana S; Sachdeva M; Joshi K
Am J Kidney Dis; 2013 Sep; 62(3):638-41. PubMed ID: 23523237
[TBL] [Abstract][Full Text] [Related]
28. Four cases of IgD multiple myeloma.
Deam DR; Busmanis IA; Hussein S; Ratnaike S
Pathology; 1991 Oct; 23(4):339-43. PubMed ID: 1784526
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
30. Coexistent light chain deposition disease, light chain cast nephropathy, and vascular light chain amyloidosis in a patient with IgD lambda multiple myeloma.
Lin ZS; Yu XJ; Qin AB; Liu MY; Wang SX; Zhou FD; Zhao MH
Int Urol Nephrol; 2021 Aug; 53(8):1729-1731. PubMed ID: 33404783
[No Abstract] [Full Text] [Related]
31. [An elderly patient with IgD myeloma associated with renal amyloidosis and acute renal failure].
Kiyatake I; Tomino Y; Funabiki K; Kubokawa Y; Shirato I; Kubota M; Koide H
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):791-6. PubMed ID: 2511365
[TBL] [Abstract][Full Text] [Related]
32. [An autopsied case of IgD. lambda Myeloma with a longer survival time (author's transl)].
Yamaguchi Y; Sawamura O; Nawata Y; Hirano Y; Kato N; Nishimoto S; Tominaga K
Rinsho Ketsueki; 1979 Feb; 20(2):140-7. PubMed ID: 108431
[No Abstract] [Full Text] [Related]
33. Light chain deposition disease involving kidney and liver in a patient with IgD myeloma.
Tsushima T; Suzuki T; Terao T; Miura D; Narita K; Takeuchi M; Shimuzu A; Matsue K
BMC Nephrol; 2021 Jan; 22(1):40. PubMed ID: 33485303
[TBL] [Abstract][Full Text] [Related]
34. Proximal tubular injury in myeloma.
Batuman V
Contrib Nephrol; 2007; 153():87-104. PubMed ID: 17075225
[TBL] [Abstract][Full Text] [Related]
35. Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma.
Ueda H; Kuno H; Takahashi D; Katsuma A; Kimura A; Nakashima A; Kato J; Momoki M; Ohba R; Dobashi N; Yamamoto I; Kawamura T; Miyazaki Y; Yokoo T
CEN Case Rep; 2020 May; 9(2):165-172. PubMed ID: 31974826
[TBL] [Abstract][Full Text] [Related]
36. A monoclonal V kappa l light chain responsible for incomplete proximal tubulopathy.
Decourt C; Bridoux F; Touchard G; Cogné M
Am J Kidney Dis; 2003 Feb; 41(2):497-504. PubMed ID: 12552516
[TBL] [Abstract][Full Text] [Related]
37. Light-chain proximal tubulopathy: a retrospective study from a single Chinese nephrology referral center.
Wang X; Yu XJ; Wang SX; Zhou FD; Zhao MH
Ren Fail; 2024 Dec; 46(1):2283587. PubMed ID: 38374684
[No Abstract] [Full Text] [Related]
38. Clinicopathologic characteristics of light chain proximal tubulopathy with light chain inclusions involving multiple renal cell types
.
Li X; Xu F; Liang D; Liang S; Zhu X; Zhang M; Huang X; Liu Z; Zeng C
Clin Nephrol; 2018 Feb; 89(2):83-92. PubMed ID: 29035194
[TBL] [Abstract][Full Text] [Related]
39. Coexistence of myeloma cast nephropathy, light chain deposition disease, and nonamyloid fibrils in a patient with multiple myeloma.
Qian Q; Leung N; Theis JD; Dogan A; Sethi S
Am J Kidney Dis; 2010 Nov; 56(5):971-6. PubMed ID: 20870327
[TBL] [Abstract][Full Text] [Related]
40. Multiple myeloma with crystal-storing histiocytosis, crystalline podocytopathy, and light chain proximal tubulopathy, revealed by retinal abnormalities: A case report.
Boudhabhay I; Titah C; Talbot A; Harel S; Verine J; Touchard G; Kaaki S; Gabison E; Vasseur V; Mauget-Faÿsse M; Sené T
Medicine (Baltimore); 2018 Dec; 97(52):e13638. PubMed ID: 30593133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
